• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Healthcare organizations seek solutions in national Measure Up, Pressure Down campaign

Article

Members of the American Medical Group Association (AMGA) are participating in Measure Up, Pressure Down, a nationwide healthcare initiative aimed at preventing, detecting, and controlling high blood pressure.

Alexandria, VA-More than 120 members of the American Medical Group Association (AMGA) have joined together to participate in Measure Up, Pressure Down, a new nationwide healthcare initiative aimed at preventing, detecting, and controlling high blood pressure.

Measure Up, Pressure Down is a 3-year campaign that targets having 80% of hypertensive patients in control of their condition by 2016. The program is spearheaded by the American Medical Group Foundation (AMGF), AMGA’s nonprofit education and research arm. Participating organizations include the U.S. Department of Health and Human Services, Mayo Clinic, Cleveland Clinic, Kaiser Permanente, and Geisinger Health System.

“By challenging medical groups and health providers to raise the bar on high blood pressure care and control, we can make a dramatic difference in the health and wellbeing of our population,” said Donald W. Fisher, PhD, CAE, president and chief executive officer of AMGA and secretary of the board of AMGF. “AMGA member medical groups are well positioned to successfully lead this critically important national effort.”

The campaign is sponsored by Novartis Pharmaceuticals Corp. and Daiichi Sankyo Inc. For more information, visit www.MeasureUpPressureDown.com.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.